Chloroplasts—the "light power plants" of plant cells—are increasingly the focus of synthetic biology. These organelles house ...

A better understanding of protein glycosylation offers insights into disease mechanisms and helps improve therapeutic medicines.

We are thrilled to welcome Matt to our leadership team,” said Allan Reine, M.D., Chief Executive Officer of Prime Medicine. “Business development has been – and will continue to be – a core pillar of ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...

Researchers have created a detailed map of chemical modifications to DNA that occur in the human brain from the earliest ...

A research team has developed pioneering technology that enables human kidney organoids to be produced on a scalable basis. These organoids can then be combined with pig kidneys outside the body and ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Inside the Booming mRNA Therapeutics MarketThe mRNA Cancer Vaccines and Therapeutics Market has emerged as one of the most transformative frontiers in oncology and biotechnology. These advanced ...

In October, the FDA granted platform technology designation to the genetically modified, non-replicating herpes simplex ... VYJUVEK is a non-invasive, topical, redosable genetic medicine designed to ...

Fast Track Designation was granted for BB-301 following FDA review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for BB-301 BB-301 has ...

With breast cancer increasing among younger women, Wellstar partnered with a start-up company specializing in breast cancer screening to help women ages 24 to 39.